GPER was found to be downregulated in HCC tissues compared to nontumor equivalents, and GPER-specific agonist G1-triggered GPER/EGFR/ERK signalling was found to be important in reducing HCC tumor viability in vitro and in vivo [46]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.